Boxer Capital, LLC - Sep 17, 2021 Form 4 Insider Report for Tyra Biosciences, Inc. (TYRA)

Role
10%+ Owner
Signature
Boxer Capital, LLC, By: /s/ Aaron I. Davis, Aaron I. Davis, Chief Executive Officer
Stock symbol
TYRA
Transactions as of
Sep 17, 2021
Transactions value $
$10,000,000
Form type
4
Date filed
9/17/2021, 04:38 PM
Previous filing
Sep 14, 2021
Next filing
Nov 19, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TYRA Common Stock Conversion of derivative security +5.7M 5.7M Sep 17, 2021 Direct F1, F2
transaction TYRA Common Stock Purchase $10M +625K +10.97% $16.00 6.32M Sep 17, 2021 Direct F2
transaction TYRA Common Stock Conversion of derivative security +288K 288K Sep 17, 2021 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TYRA Series A Preferred Stock Conversion of derivative security $0 -1.48M -100% $0.00* 0 Sep 17, 2021 Common Stock 3.84M Direct F1, F2
transaction TYRA Series A Preferred Stock Conversion of derivative security $0 -95.5K -100% $0.00* 0 Sep 17, 2021 Common Stock 248K Direct F1, F3
transaction TYRA Series B Preferred Stock Conversion of derivative security $0 -714K -100% $0.00* 0 Sep 17, 2021 Common Stock 1.85M Direct F1, F2
transaction TYRA Series B Preferred Stock Conversion of derivative security $0 -15.4K -100% $0.00* 0 Sep 17, 2021 Common Stock 40K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On September 17, 2021, each share of Series A Preferred Stock and each share of Series B Preferred Stock converted into shares of the Issuer's common stock at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
F2 These securities are held directly by Boxer Capital, LLC ("Boxer Capital"), which may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc. ("Boxer Management"), (iii) Joseph C. Lewis, (iv) MVA Investors, LLC and (v) Aaron I. Davis (collectively, the "Boxer Group"), and indirectly by Boxer Management and Joseph C. Lewis by virtue of their ownership in Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein.
F3 These securities are held directly by MVA Investors, which may be deemed to be a member of the Boxer Group for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, and indirectly by Mr. Davis who is a member of and has voting and dispositive power over securities held by MVA Investors. Each member of the Boxer Group other than MVA Investors disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein.